Presentation is loading. Please wait.

Presentation is loading. Please wait.

Karen M. Williamson RN, MScN, PhD(c) Maher M. El-Masri RN, PhD

Similar presentations


Presentation on theme: "Karen M. Williamson RN, MScN, PhD(c) Maher M. El-Masri RN, PhD"— Presentation transcript:

1 Severe Acute Respiratory Syndrome Another Challenge for Critical Care Nurses
Karen M. Williamson RN, MScN, PhD(c) Maher M. El-Masri RN, PhD Susan M. Fox-Wasylyshyn RN, PhD

2 What is SARS? Viral Disease Primarily airborne
Contracted by exposure to a new form of coronavirus Symptoms are common: fever; non-productive cough No vaccine or definitive treatment Epidemic is NOT over: It is CONTAINED

3 Historical Background
First case of SARS: November 2002 Started in China Nurses, particularly ICU and ER nurses were at risk for contracting the disease

4 SARS Statistics: 2004 Total probable/suspected
China: 2889 cases USA: 220 cases Canada: 438 cases In Canada: 100 of these were HCWs HCWs contracted SARS d/t: caring for undiagnosed SARS patients who were not isolated; contact with ill family members

5 Etiology and Transmission
SARS viral in origin; contracted by exposure to a novel coronovirus Transmitted: droplet spread; surface contamination; close contact

6 Prognosis Greatest in patients aged 65 years and older (50%)
Risk factors: older age, diabetes, tachycardia, elevated creatinine kinase and LDH levels Predictors of mortality: HTN, diabetes, age, smokers, immunosuppression, respiratory infections

7 Case Definition Clinical: Temp: 100.4°F
Cough, SOB, dyspnea, hypoxia, pneumonia ARDS

8 Case Definition (cont’d)
Epidemiologic: Travel Close contact Laboratory: Detection SARS-CoV Detection SARS-CoV RNA by RT-PCR Isolation SARS-CoV

9 Clinical Manifestations
Fever greater than 100.4°F Non-productive cough Dyspnea Radiologic infiltrates: O2 sat. on room air < 95% No alternative diagnosis can fully explain the illness

10 Diagnostic Criteria Testing of SARS-CoV based on detection of virus or antibody response to viral infection RT-PCR (nasopharangeal and stool) ELISA or IFA (serum)

11 The Inter-epidemic period 2004/2005
Definition of SARS alert is based on clinical evidence in the following situations: A. Individual contact/travel B. 2 or more HCWs exhibiting S&S C. 3 or more persons (HCWs and others) with symptoms

12 Current and Future of Treatment for SARS
Antibiotics (not successful) Anti-virals Corticosteroids Supportive intensive care Immunization: in the beginning phase

13 Clinical Management Infection Control+++
Early identification and patient isolation Patients and HCWs should wear masks/HCWs wear eye protection, gloves, long sleeved gowns, respirator masks, wash hands with ETOH-based skin disinfectants,

14 Clinical Management (cont’d)
Highly recommended: SARS patients should be placed in a room with negative pressure ventilation Lower tidal volumes during mechanical ventilation Continuity of care

15 Implications for Critical Care Nurses
Be viligant for any non-ordinary reports of acute respiratory illnesses Full infection control Become involved in collaborative policy and research efforts to understand SARS and effective clinical management

16 Conclusion SARS is highly contagious
The SARS epidemic has only been contained! Adherence by critical nurses to optimal infection control procedures is MANDATORY!


Download ppt "Karen M. Williamson RN, MScN, PhD(c) Maher M. El-Masri RN, PhD"

Similar presentations


Ads by Google